doxapram has been researched along with Anxiety in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxapram at 4 mg/kg increased anxiety-related behaviors in all four anxiety models." | 3.72 | Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala. ( Apergis, J; Gorman, JM; LeDoux, JE; Sullivan, GM, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sullivan, GM | 1 |
| Apergis, J | 1 |
| Gorman, JM | 1 |
| LeDoux, JE | 1 |
1 other study available for doxapram and Anxiety
| Article | Year |
|---|---|
Rodent doxapram model of panic: behavioral effects and c-Fos immunoreactivity in the amygdala.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning | 2003 |